May 13, 2019 / 11:48 PM / 2 months ago

Becton Dickinson unit settles U.S. probe over unapproved medical devices

Becton Dickinson subsidiary CareFusion has agreed to pay $3.3 million to resolve claims that it bought and sold medical devices that did not have approval by the Food and Drug Administration, the Justice Department said on Monday.

San Diego-based CareFusion admitted to buying and selling unapproved devices as part of the civil settlement announced by Manhattan U.S. Attorney Geoffrey Berman, which resolves claims first raised against it in a whistleblower lawsuit.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2E5P3b6

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below